Send us Feedback

BioMarin Pharmaceutical (BMRN)
Analysis
Data
Financials
No Sales Breakout Data.
Balance Sheet    (USD)
Annual | Quarterly
QUARTER ENDING older 30-SEP
2008		 31-DEC
2008		 31-MAR
2009		 30-JUN
2009		 30-SEP
2009		 newer
Cash & Equivalents 271M 223M 215M 200M 192M
Short Term Investments 292M 337M 337M 146M 172M
Accounts Receivable 51.1M 54.3M 61.4M 72.6M 68.4M
Inventories 68.1M 73.2M 76.4M 72.8M 75.4M
Pre-paid Expenses 0 0 0 0 0
Deferred Tax Assets 0 0 0 0 0
Other Current Assets 14.8M 50.4M 23.9M 15.2M 13.1M
Total Current Assets 697M 738M 714M 507M 520M
Property, Plant & Equipment 111M 125M 142M 160M 182M
Goodwill & Intangibles 27.3M 28.9M 27.6M 25.7M 25.5M
Other Long-term Assets 24.0M 15.1M 16.9M 152M 142M
Total Long-Term Assets 162M 169M 187M 337M 349M
Total Assets 859M 907M 900M 844M 869M
Accounts Payable 2.03M 58.9M 6.38M 3.90M 2.87M
Accrued Expenses 1.79M 0 0 0 0
Short Term Debt 0 70.7M 70.3M 0 0
Other Current Liabilities 73.5M 489K 120K 929K 149K
Total Current Liabilities 121M 130M 126M 60.0M 64.1M
Long Term Debt 497M 497M 497M 497M 497M
Capital Lease Obligations 0 0 0 0 0
Deferred Income Tax 0 0 0 0 0
Other Long-term Liabilities 3.16M 2.86M 2.95M 3.89M 4.35M
Total Long-term Liabilities 500M 500M 500M 501M 501M
Minority Interest 0 0 0 0 0
Total Liabilities 621M 630M 626M 561M 566M
Preferred Stock 0 0 0 0 0
Common Par 100K 100K 100K 100K 101K
Additional Paid-In Capital 842M 853M 862M 873M 888M
Retained Earnings -601M -577M -590M -588M -582M
Treasury Stock 0 0 0 0 0
Other Equity -2.75M 224K 1.22M -1.61M -2.42M
Total Shareholder's Equity 238M 277M 274M 283M 304M
 
 
 
 
 
Data Sources:
Market and financial statement data provided by NASDAQ, BATS Exchange, SEC and Xignite Inc. Industry and operating metrics collected from company filings via EDGAR online. For more information on sources and calculations click here.
Wikinvest © 2006, 2007, 2008, 2009. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki